In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CP Pharmaceuticals Ltd.

Division of Wockhardt Ltd.

Latest From CP Pharmaceuticals Ltd.

Asia Deal Watch: Daiichi Sankyo Acquires Partial Asian Rights To Three Astellas Drugs

Daiichi Sankyo obtains rights to antiemetic Nasea and the anti-hypertension drugs Perdipine and Oldeca. Mitsubishi Tanabe licenses Asian rights to Viela’s inebilizumab for a rare eye disorder.

Deals Business Strategies

Mind The Gap: UK Gender Pay Report Is Time Bomb For Pharma

Pfizer, Novartis, Norgine and CP Pharmaceuticals have reported their UK gender pay gap data. With early reporters in pharma and other sectors already showing that at most organizations, men have more of the higher-paid jobs, expect an outcry on Apr. 4, when all larger employers must publish by law.

Business Strategies Companies

Recent Dealmaking (9/2003)

Summarizing the month in European dealmaking.

See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Wockhardt Ltd.
  • Senior Management
  • Charles Savage, Chmn. & CEO
  • Contact Info
  • CP Pharmaceuticals Ltd.
    Phone: (44) 1978 661261
    Wrexham Industrial Estate
    Ash Rd. N.
    Wrexham, LL13 9UF